Siskinds LLP class actions partner, Jill McCartney, and lawyer, Jordyn Liebman, were featured in a CTV News article by CTVnews.ca writer Alexandra Mae Jones. The article details Siskinds LLP’s proposed class action lawsuit against Novo Nordisk, the manufacturer of Ozempic, Rybelsus, and Wegovy. It is alleged that Novo Nordisk failed to provide sufficient disclosure about side effects linked to these drugs, including stomach paralysis and gallbladder disease.
Watch the video and read the full article here: Ozempic lawsuit: Proposed class action alleges serious harm | CTV News
If you or someone you know has used Ozempic, Rybelsus, or Wegovy and has suffered serious stomach, gallbladder, or other gastrointestinal harms, Siskinds may be able to help.
Visit siskinds.com/ozempic and complete the form at the bottom of the page or call 1-800-461-6166. Quebec residents should contact Siskinds Desmeules by phone at 418-694-2009 or by email at [email protected].